ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00795418
Recruitment Status : Completed
First Posted : November 21, 2008
Last Update Posted : May 4, 2012
Sponsor:
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2010
  Study Completion Date : No date given
  Certification/Extension First Submitted : May 2, 2012